{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:44:30Z","timestamp":1777445070856,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002636","name":"Inje University","doi-asserted-by":"crossref","award":["2016"],"award-info":[{"award-number":["2016"]}],"id":[{"id":"10.13039\/501100002636","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00417-019-04394-z","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T11:02:43Z","timestamp":1561028563000},"page":"1709-1717","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Type I pig collagen enhances the efficacy of PEDF 34-mer peptide in a mouse model of laser-induced choroidal neovascularization"],"prefix":"10.1007","volume":"257","author":[{"given":"Hyun Woong","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kug-Hwan","family":"Roh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Jae","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na-Young","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il-Whan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-2010","authenticated-orcid":false,"given":"SaeGwang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"4394_CR1","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY (2012) Age-related macular degeneration. Lancet 379:1728\u20131738. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(12)60282-7","journal-title":"Lancet"},{"key":"4394_CR2","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106\u2013e116. \n                    https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1","journal-title":"Lancet Glob Health"},{"key":"4394_CR3","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","volume":"364","author":"DF Martin","year":"2011","unstructured":"Group CR, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 364:1897\u20131908. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1102673","journal-title":"N Engl J Med"},{"key":"4394_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1126\/science.285.5425.245","volume":"285","author":"DW Dawson","year":"1999","unstructured":"Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285:245\u2013248","journal-title":"Science"},{"key":"4394_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.exer.2005.05.007","volume":"82","author":"IA Bhutto","year":"2006","unstructured":"Bhutto IA, McLeod DS, Hasegawa T, Kim SY, Merges C, Tong P, Lutty GA (2006) Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 82:99\u2013110. \n                    https:\/\/doi.org\/10.1016\/j.exer.2005.05.007","journal-title":"Exp Eye Res"},{"key":"4394_CR6","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1167\/iovs.04-0172","volume":"45","author":"RS Apte","year":"2004","unstructured":"Apte RS, Barreiro RA, Duh E, Volpert O, Ferguson TA (2004) Stimulation of neovascularization by the anti-angiogenic factor PEDF. Invest Ophthalmol Vis Sci 45:4491\u20134497. \n                    https:\/\/doi.org\/10.1167\/iovs.04-0172","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4394_CR7","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1167\/iovs.09-4455","volume":"51","author":"J Amaral","year":"2010","unstructured":"Amaral J, Becerra SP (2010) Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization. Invest Ophthalmol Vis Sci 51:1318\u20131326. \n                    https:\/\/doi.org\/10.1167\/iovs.09-4455","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4394_CR8","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1128\/MCB.01211-10","volume":"31","author":"K Park","year":"2011","unstructured":"Park K, Lee K, Zhang B, Zhou T, He X, Gao G, Murray AR, Ma JX (2011) Identification of a novel inhibitor of the canonical Wnt pathway. Mol Cell Biol 31:3038\u20133051. \n                    https:\/\/doi.org\/10.1128\/MCB.01211-10","journal-title":"Mol Cell Biol"},{"key":"4394_CR9","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1530\/JOE-14-0065","volume":"222","author":"M Elahy","year":"2014","unstructured":"Elahy M, Baindur-Hudson S, Cruzat VF, Newsholme P, Dass CR (2014) Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy. J Endocrinol 222:R129\u2013R139. \n                    https:\/\/doi.org\/10.1530\/JOE-14-0065","journal-title":"J Endocrinol"},{"key":"4394_CR10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/cbdd.12055","volume":"81","author":"DJ Craik","year":"2013","unstructured":"Craik DJ, Fairlie DP, Liras S, Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81:136\u2013147. \n                    https:\/\/doi.org\/10.1111\/cbdd.12055","journal-title":"Chem Biol Drug Des"},{"key":"4394_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1042\/CS20130463","volume":"128","author":"X He","year":"2015","unstructured":"He X, Cheng R, Benyajati S, Ma JX (2015) PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases. Clin Sci (Lond) 128:805\u2013823. \n                    https:\/\/doi.org\/10.1042\/CS20130463","journal-title":"Clin Sci (Lond)"},{"key":"4394_CR12","doi-asserted-by":"publisher","first-page":"33310","DOI":"10.1074\/jbc.M801287200","volume":"283","author":"SP Becerra","year":"2008","unstructured":"Becerra SP, Perez-Mediavilla LA, Weldon JE, Locatelli-Hoops S, Senanayake P, Notari L, Notario V, Hollyfield JG (2008) Pigment epithelium-derived factor binds to hyaluronan. Mapping of a hyaluronan binding site. J Biol Chem 283:33310\u201333320. \n                    https:\/\/doi.org\/10.1074\/jbc.M801287200","journal-title":"J Biol Chem"},{"key":"4394_CR13","doi-asserted-by":"publisher","first-page":"45400","DOI":"10.1074\/jbc.M208339200","volume":"277","author":"C Meyer","year":"2002","unstructured":"Meyer C, Notari L, Becerra SP (2002) Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity. J Biol Chem 277:45400\u201345407. \n                    https:\/\/doi.org\/10.1074\/jbc.M208339200","journal-title":"J Biol Chem"},{"key":"4394_CR14","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1021\/bi0206558","volume":"42","author":"N Yasui","year":"2003","unstructured":"Yasui N, Mori T, Morito D, Matsushita O, Kourai H, Nagata K, Koide T (2003) Dual-site recognition of different extracellular matrix components by anti-angiogenic\/neurotrophic serpin, PEDF. Biochemistry 42:3160\u20133167. \n                    https:\/\/doi.org\/10.1021\/bi0206558","journal-title":"Biochemistry"},{"key":"4394_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0939-6411(98)00017-4","volume":"45","author":"W Friess","year":"1998","unstructured":"Friess W (1998) Collagen--biomaterial for drug delivery. Eur J Pharm Biopharm 45:113\u2013136","journal-title":"Eur J Pharm Biopharm"},{"key":"4394_CR16","doi-asserted-by":"publisher","first-page":"42514","DOI":"10.1074\/jbc.M111.296590","volume":"286","author":"J Cai","year":"2011","unstructured":"Cai J, Chen Z, Ruan Q, Han S, Liu L, Qi X, Boye SL, Hauswirth WW, Grant MB, Boulton ME (2011) Gamma-secretase and presenilin mediate cleavage and phosphorylation of vascular endothelial growth factor receptor-1. J Biol Chem 286:42514\u201342523. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.296590","journal-title":"J Biol Chem"},{"key":"4394_CR17","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1074\/jbc.M507401200","volume":"281","author":"J Cai","year":"2006","unstructured":"Cai J, Jiang WG, Grant MB, Boulton M (2006) Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1. J Biol Chem 281:3604\u20133613. \n                    https:\/\/doi.org\/10.1074\/jbc.M507401200","journal-title":"J Biol Chem"},{"key":"4394_CR18","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/jps.22054","volume":"99","author":"DS Pisal","year":"2010","unstructured":"Pisal DS, Kosloski MP, Balu-Iyer SV (2010) Delivery of therapeutic proteins. J Pharm Sci 99:2557\u20132575. \n                    https:\/\/doi.org\/10.1002\/jps.22054","journal-title":"J Pharm Sci"},{"key":"4394_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.exer.2006.04.014","volume":"83","author":"H Li","year":"2006","unstructured":"Li H, Tran VV, Hu Y, Mark Saltzman W, Barnstable CJ, Tombran-Tink J (2006) A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres. Exp Eye Res 83:824\u2013833. \n                    https:\/\/doi.org\/10.1016\/j.exer.2006.04.014","journal-title":"Exp Eye Res"},{"key":"4394_CR20","first-page":"1540","volume":"32","author":"CM Seery","year":"1991","unstructured":"Seery CM, Davison PF (1991) Collagens of the bovine vitreous. Invest Ophthalmol Vis Sci 32:1540\u20131550","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4394_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3980\/J.ISSN.2222-3959.2013.02.22","volume":"6","author":"X Liu","year":"2013","unstructured":"Liu X, Chen HH, Zhang LW (2013) Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathy. Int J Ophthalmol 6:221\u2013227. \n                    https:\/\/doi.org\/10.3980\/J.ISSN.2222-3959.2013.02.22","journal-title":"Int J Ophthalmol"},{"key":"4394_CR22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.mcn.2015.08.001","volume":"68","author":"V Vigneswara","year":"2015","unstructured":"Vigneswara V, Esmaeili M, Deer L, Berry M, Logan A, Ahmed Z (2015) Eye drop delivery of pigment epithelium-derived factor-34 promotes retinal ganglion cell neuroprotection and axon regeneration. Mol Cell Neurosci 68:212\u2013221. \n                    https:\/\/doi.org\/10.1016\/j.mcn.2015.08.001","journal-title":"Mol Cell Neurosci"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04394-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04394-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04394-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T23:10:05Z","timestamp":1592521805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04394-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4394"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04394-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"16 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animals were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Animal experiments were examined and approved by the Institutional Animal Care and Use Committee of INJE University (Protocol No. 2016-007).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}